Cells, 2021 · DOI: https://doi.org/10.3390/cells10061339 · Published: May 28, 2021
Astrocytes, typically seen as hindering nerve regeneration in the central nervous system due to scar formation, have shown promise in spinal cord injury recovery by becoming growth-supportive. This review explores whether astrocytes and Müller cells in the retina, which react to retinal and optic nerve damage, can be similarly induced to support retinal ganglion cell (RGC) survival and axon regeneration. The review identifies potential molecular pathways that induce growth-supportive astrocytes in the spinal cord. It suggests that activating these pathways in the retina could be a new therapeutic approach for promoting RGC survival and axon regeneration in retinal degenerative diseases. Epidermal Growth Factor (EGF) signaling in the spinal cord seems to induce the A2 phenotype, it is currently unknown whether EGFR signaling can also generate A2 astrocytes in the retina and promote RGC survival and axon regeneration after injury.
Stimulating specific molecular pathways in retinal macroglia could lead to new treatments for retinal degenerative diseases.
More research is needed to understand the reparative roles of retinal gliosis and the effects of EGFR ligand-induced EGFR signaling on RGC survival and axon regeneration.
Future research should evaluate the efficacy of EGFR ligand-based eye drops after ONC.